Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Para-n-benzene - sulfoxy-n containing doai – and said benzene...
Patent
1998-07-17
2000-09-12
Yucel, Remy
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Para-n-benzene - sulfoxy-n containing doai, and said benzene...
424 952, A01N 5100
Patent
active
061178586
ABSTRACT:
The invention relates to a new and improved pharmaceutical composition and method for delivery of therapeutic agents. The methods and composition of the invention can be used with several therapeutic agents and can achieve site specific delivery of a therapeutic or diagnostic substance. This can allow for lower doses and for improved efficacy with drugs which traditionally reach targeted sites and can result in improved utility for agents such as oligonucleotides and polynucleotides which are plagued with problems with biodistribution.
REFERENCES:
patent: 4572203 (1986-02-01), Feinstein
patent: 4634586 (1987-01-01), Goodwin et al.
patent: 4718433 (1988-01-01), Feinstein
patent: 4774958 (1988-10-01), Feinstein
patent: 4844882 (1989-07-01), Widder et al.
patent: 4957656 (1990-09-01), Cerny et al.
patent: 5040537 (1991-08-01), Katakura
patent: 5107842 (1992-04-01), Levene et al.
patent: 5255683 (1993-10-01), Monaghan
patent: 5304325 (1994-04-01), Kaufman et al.
patent: 5310540 (1994-05-01), Giddey et al.
patent: 5315997 (1994-05-01), Widder et al.
patent: 5315998 (1994-05-01), Tachibana et al.
patent: 5380519 (1995-01-01), Schneider et al.
patent: 5385147 (1995-01-01), Anderson et al.
patent: 5385725 (1995-01-01), Lin et al.
patent: 5393524 (1995-02-01), Quay
patent: 5401493 (1995-03-01), Lohrmann et al.
patent: 5409688 (1995-04-01), Quay
patent: 5410516 (1995-04-01), Uhlendorf et al.
patent: 5413774 (1995-05-01), Schneider et al.
patent: 5439686 (1995-08-01), Desai et al.
patent: 5445813 (1995-08-01), Schneider et al.
patent: 5512268 (1996-04-01), Grinstaff et al.
patent: 5540909 (1996-07-01), Schutt
patent: 5542935 (1996-08-01), Unger et al.
patent: 5552133 (1996-09-01), Lambert et al.
patent: 5558853 (1996-09-01), Quay
patent: 5560364 (1996-10-01), Porter
patent: 5567415 (1996-10-01), Porter
patent: 5580859 (1996-12-01), Felgner et al.
patent: 5585479 (1996-12-01), Hoke et al.
Porter et al. Circulation. vol. 92 (9) pp. 2391-2395, Nov. 1995.
Porter et al. J. American College of Cardiology. vol. 25(2) pp. 509-515, Feb. 1995.
Anderson, Editorial, "Gene Therapy for Genetic Diseases", Human Gene Therapy, vol. 5, pp. 281-282 (1994), Mary Ann Liebert, Inc., Publishers.
Bleeker, H., "On the Application of Ultrasonic Contrast Agents for Blood Flowmetry and Assessment of Cardiac Perfusion", Ultrasound Med, 9:461-471 (1990).
Brown, "New Media, Researchers `Oversold` Gene Therapy, Advisory Panel Says", The Washington Post (Dec. 8, 1995).
Challita & Kohn, "Lack of Expression from a Retroviral Vector After Transduction of Murine Hematopoietic Stem Cells is Associated with Methylation in vivo", Proc. Natl. Acad. Sci., USA, vol. 91, pp. 2567-2571 (Mar. 1994).
Coghlan, Focus, Editorial, "Gene Dream Fades Away", New Scientist, vol. 148, No. 2005, pp. 14-15 (Nov. 25, 1995).
Gura, T., "Antisense Has Growing Pains", Science, vol. 270, pp. 575-577 (1995).
Jaroff, "Keys to the Kingdom", Time, vol. 148, No. 14, pp. 25-29 (1996).
Kricsfeld, A., "Detection of Regional Perfusion Abnormalities During Adenoosine Stress Echocardiography Using Intravenous Perfluoropropane-enhanced Sonicated Dextrose Albumin", J. Am. Col. of Card., special issue, p. 38A Feb. 1995 (abstract XP000577057).
Marshall, "Gene Therapy's Growing Pains", Science, vol. 269, pp. 1050-1055 (Aug. 25, 1995).
Orkin et al., Report and Recommendations of the Panel to Assess the NIH Investment in Research on Gene Therapy (Dec. 7, 1995).
Porter et al., "The Mechanism and Clinical Implication of Improved Left Ventricular Videointensity Following Intravenous Injection of Multi-fold Dilutions of Albumin with Dextrose", International Journal of Cardiac Imaging, vol. 11, pp. 117-125 (1995).
Porter et al., "Transient Myocardial Contrast After Initial Exposure to Diagnostic Ultrasound Pressures with Minute Doses of Intravenously Injected Microbubbles: Demonstration and Potential Mechanisms", Circulation, vol. 92, No. 9, pp. 2391-2395 (1995).
Porter, T., "Echocardiographic Detection of Residual Coronary Flow Abnormalities and Stenosis Severity After Coronary Reperfusion Using Intravenous Perfluoropropane-enhanced Sonicated Dextrose Albumin", 44th Annual Scientific Session of the American College of Cardiology, New Orleans, LA, USA, Mar. 19-22, 1995. J. Am. Col. of Card., special issue, p. 205AFeb. 1995 (abstract 95-60) XP000577058.
Porter, T., "Multifold Sonicated Dilutions of Albumin with Fifty Percent Dextrose Improve Left Ventricular Contrast Videointensity After Intravenous Injection in Human Beings", J. Am. Soc. Echocard., 7(5) 465-471 (1994).
Porter, T., "Myocardial Contrast Echocardiography for the Assessment of Coronary Blood Flow Reserve: Validation in Humans", JACC, 21(2) 349-355 (1993).
Porter, T., "Noninvasive Indentification of Acute Myocardial Ischemia and Reperfusion with Contrast Ultrasound Using Intravenous Perfluoropropane-Exposed Sonicated Dextrose Albumin", J. Am. Col. of Card., 26(1) 33-40 (1995).
Xie, F., "Acute Myocardial Ischemia and Reperfusion can be Visually Identified Non-invasively with Intravenous Perfluoropropane-Enhanced Sonicated Dextrose Albumin Ultrasound Contrast", Abstract From the 67th Scientific Sessions Dallas Convention Center, Dallas TX, Nov. 14-17, 1994, 90(2) Part 2, p. 1555 Oct. 1994 (abstract XP000577054).
Xie, F., "Perfluoropropane enhanced Sonicated Dextrose Albumin Produces Visually Apparent Consistent Myocardial Opecification with Physiologic Washout and Minimal Homodynamic Changes Following... Injection", Abstract From the 67th Scientific Sessions Dallas Convention Center, Dallas TX, Nov. 14-17, 1994, 90(4) Part 2, p. 269 Oct. 1994 (abstract XP000577055).
Iversen Patrick L.
Porter Thomas R.
Gorthey LeeAnn
Nebel Heidi S.
The Board of Regents of the University of Nebraska
Yucel Remy
LandOfFree
Compositions and methods for altering the biodistribution of bio does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for altering the biodistribution of bio, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for altering the biodistribution of bio will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-96291